These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34565654)

  • 1. Successful treatment of congenital myasthenic syndrome caused by a novel compound heterozygous variant in RAPSN.
    Saito M; Ogasawara M; Inaba Y; Osawa Y; Nishioka M; Yamauchi S; Atsumi K; Takeuchi S; Imai K; Motobayashi M; Misawa Y; Iida A; Nishino I
    Brain Dev; 2022 Jan; 44(1):50-55. PubMed ID: 34565654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital myasthenic syndromes in childhood: diagnostic and management challenges.
    Kinali M; Beeson D; Pitt MC; Jungbluth H; Simonds AK; Aloysius A; Cockerill H; Davis T; Palace J; Manzur AY; Jimenez-Mallebrera C; Sewry C; Muntoni F; Robb SA
    J Neuroimmunol; 2008 Sep; 201-202():6-12. PubMed ID: 18707767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapsyn N88K is a frequent cause of congenital myasthenic syndromes in European patients.
    Müller JS; Mildner G; Müller-Felber W; Schara U; Krampfl K; Petersen B; Petrova S; Stucka R; Mortier W; Bufler J; Kurlemann G; Huebner A; Merlini L; Lochmüller H; Abicht A
    Neurology; 2003 Jun; 60(11):1805-10. PubMed ID: 12796535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical variability of early-onset congenital myasthenic syndrome due to biallelic RAPSN mutations in Brazil.
    Estephan EP; Zambon AA; Marchiori PE; da Silva AMS; Caldas VM; Moreno CAM; Reed UC; Horvath R; Töpf A; Lochmüller H; Zanoteli E
    Neuromuscul Disord; 2018 Nov; 28(11):961-964. PubMed ID: 30266223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up in patients with congenital myasthenic syndrome due to RAPSN mutations.
    Natera-de Benito D; Bestué M; Vilchez JJ; Evangelista T; Töpf A; García-Ribes A; Trujillo-Tiebas MJ; García-Hoyos M; Ortez C; Camacho A; Jiménez E; Dusl M; Abicht A; Lochmüller H; Colomer J; Nascimento A
    Neuromuscul Disord; 2016 Feb; 26(2):153-9. PubMed ID: 26782015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique presentation of rapidly fluctuating symptoms in a child with congenital myasthenic syndrome due to RAPSN mutation.
    Kumar A; Asghar S; Kavanagh R; Wicklund MP
    Muscle Nerve; 2018 Oct; 58(4):E23-E24. PubMed ID: 30028532
    [No Abstract]   [Full Text] [Related]  

  • 7. Congenital myasthenic syndromes in the Thai population: Clinical findings and novel mutations.
    Pattrakornkul N; Ittiwut C; Boonsimma P; Boonyapisit K; Khongkhatithum C; Sanmaneechai O; Suphapeetiporn K; Shotelersuk V
    Neuromuscul Disord; 2020 Oct; 30(10):851-858. PubMed ID: 32978031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired receptor clustering in congenital myasthenic syndrome with novel RAPSN mutations.
    Müller JS; Baumeister SK; Rasic VM; Krause S; Todorovic S; Kugler K; Müller-Felber W; Abicht A; Lochmüller H
    Neurology; 2006 Oct; 67(7):1159-64. PubMed ID: 16931511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A newly identified chromosomal microdeletion of the rapsyn gene causes a congenital myasthenic syndrome.
    Müller JS; Abicht A; Christen HJ; Stucka R; Schara U; Mortier W; Huebner A; Lochmüller H
    Neuromuscul Disord; 2004 Nov; 14(11):744-9. PubMed ID: 15482960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The longest reported sibling survivors of a severe form of congenital myasthenic syndrome with the ALG14 pathogenic variant.
    Katata Y; Uneoka S; Saijyo N; Aihara Y; Miyazoe T; Koyamaishi S; Oikawa Y; Ito Y; Abe Y; Numata-Uematsu Y; Takayama J; Kikuchi A; Tamiya G; Uematsu M; Kure S
    Am J Med Genet A; 2022 Apr; 188(4):1293-1298. PubMed ID: 34971077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1.
    Finlayson S; Palace J; Belaya K; Walls TJ; Norwood F; Burke G; Holton JL; Pascual-Pascual SI; Cossins J; Beeson D
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1119-25. PubMed ID: 23447650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Congenital myasthenic syndromes: difficulties in the diagnosis, course and prognosis, and therapy--The French National Congenital Myasthenic Syndrome Network experience].
    Eymard B; Stojkovic T; Sternberg D; Richard P; Nicole S; Fournier E; Béhin A; Laforêt P; Servais L; Romero N; Fardeau M; Hantaï D;
    Rev Neurol (Paris); 2013 Feb; 169 Suppl 1():S45-55. PubMed ID: 23452772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiexon deletions account for 15% of congenital myasthenic syndromes with RAPSN mutations after negative DNA sequencing.
    Gaudon K; Pénisson-Besnier I; Chabrol B; Bouhour F; Demay L; Ben Ammar A; Bauché S; Vial C; Nicolas G; Eymard B; Hantaï D; Richard P
    J Med Genet; 2010 Dec; 47(12):795-6. PubMed ID: 20930056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VAMP1-Related Congenital Myasthenic Syndrome: A Case Report and Literature Review.
    Yıldırım M; Yarenci GB; Genç MB; Uçar Çİ; Bayav S; Tekin MN; Bektaş Ö; Teber S
    Neuropediatrics; 2024 Jun; 55(3):200-204. PubMed ID: 38531369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrement with high frequency repetitive nerve stimulation in a RAPSN congenital myasthenic syndrome.
    LoRusso SJ; Iyadurai SJ
    Muscle Nerve; 2018 Mar; 57(3):E106-E108. PubMed ID: 29053879
    [No Abstract]   [Full Text] [Related]  

  • 16. Congenital stridor with feeding difficulty as a presenting symptom of Dok7 congenital myasthenic syndrome.
    Jephson CG; Mills NA; Pitt MC; Beeson D; Aloysius A; Muntoni F; Robb SA; Bailey CM
    Int J Pediatr Otorhinolaryngol; 2010 Sep; 74(9):991-4. PubMed ID: 20554332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of next-generation sequencing as a diagnostic tool for congenital myasthenic syndrome.
    Das AS; Agamanolis DP; Cohen BH
    Pediatr Neurol; 2014 Nov; 51(5):717-20. PubMed ID: 25194721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preimplantation genetic testing as a means of preventing hereditary congenital myasthenic syndrome caused by RAPSN.
    Zhang Z; Zhang X; Xue H; Chu L; Hu L; Bi X; Zhu P; Zhang D; Chen J; Cui X; Kong L; Liang B; Wu X
    Mol Genet Genomic Med; 2024 Mar; 12(3):e2409. PubMed ID: 38511267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel truncating RAPSN mutations causing congenital myasthenic syndrome responsive to 3,4-diaminopyridine.
    Banwell BL; Ohno K; Sieb JP; Engel AG
    Neuromuscul Disord; 2004 Mar; 14(3):202-7. PubMed ID: 15036330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective Treatment With Albuterol in DOK7 Congenital Myasthenic Syndrome in Children.
    Tsao CY
    Pediatr Neurol; 2016 Jan; 54():85-7. PubMed ID: 26552645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.